{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:18Z","timestamp":1707524598986},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,5]]},"DOI":"10.7759\/cureus.26585","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T19:41:06Z","timestamp":1657050066000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Hospitalized Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) With and Without a History of Peripheral Artery Disease"],"prefix":"10.7759","author":[{"given":"Ayham","family":"Khrais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Kahlam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin E","year":"2004","unstructured":"Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004, 110:738-43. 10.1161\/01.CIR.0000137913.26087.F0","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison MA","year":"2007","unstructured":"Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007, 32:328-33. 10.1016\/j.amepre.2006.12.010","journal-title":"Am J Prev Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(10)70437-2","article-title":"One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry","volume":"26","author":"Smolderen KG","year":"2010","unstructured":"Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, Mahoney EM. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010, 26:297-305. 10.1016\/s0828-282x(10)70437-2","journal-title":"Can J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2011.09.016","article-title":"Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease","volume":"43","author":"Smolderen KG","year":"2012","unstructured":"Smolderen KG, Wang K, de Pouvourville G, et al.. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012, 43:198-207. 10.1016\/j.ejvs.2011.09.016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes FG","year":"2008","unstructured":"Fowkes FG, Murray GD, Butcher I, et al.. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008, 300:197-208. 10.1001\/jama.300.2.197","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review","volume":"293","author":"Agnelli G","year":"2020","unstructured":"Agnelli G, Belch JJ, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis. 2020, 293:94-100. 10.1016\/j.atherosclerosis.2019.09.012","journal-title":"Atherosclerosis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.4.453","article-title":"Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms","volume":"292","author":"McDermott MM","year":"2004","unstructured":"McDermott MM, Liu K, Greenland P, et al.. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004, 292:453-61. 10.1001\/jama.292.4.453","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli A","year":"2007","unstructured":"Andriulli A, Loperfido S, Napolitano G, et al.. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007, 102:1781-8. 10.1111\/j.1572-0241.2007.01279.x","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4043-3","article-title":"Efficacy and safety of propofol-mediated sedation for outpatient endoscopic retrograde cholangiopancreatography (ERCP)","volume":"61","author":"Yang JF","year":"2016","unstructured":"Yang JF, Farooq P, Zwilling K, Patel D, Siddiqui AA. Efficacy and safety of propofol-mediated sedation for outpatient endoscopic retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 2016, 61:1686-91. 10.1007\/s10620-016-4043-3","journal-title":"Dig Dis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.285","article-title":"Anesthetist-directed sedation favors success of advanced endoscopic procedures","volume":"112","author":"Buxbaum J","year":"2017","unstructured":"Buxbaum J, Roth N, Motamedi N, et al.. Anesthetist-directed sedation favors success of advanced endoscopic procedures. Am J Gastroenterol. 2017, 112:290-6. 10.1038\/ajg.2016.285","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","unstructured":"Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324:71-86. 10.1136\/bmj.324.7329.71","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart RG","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146:857-67. 10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00615-2","article-title":"Prevalence of visceral artery involvement in patients with peripheral artery disease found on run-off MRA","volume":"21","author":"Streckenbach F","year":"2021","unstructured":"Streckenbach F, Meinel FG, Ammermann F, et al.. Prevalence of visceral artery involvement in patients with peripheral artery disease found on run-off MRA. BMC Med Imaging. 2021, 21:93. 10.1186\/s12880-021-00615-2","journal-title":"BMC Med Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)80159-4","article-title":"Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors","volume":"99","author":"Lee JG","year":"1995","unstructured":"Lee JG, Krucoff MW, Brazer SR. Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors. Am J Med. 1995, 99:270-5. 10.1016\/s0002-9343(99)80159-4","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005473","article-title":"Risks of upper gastrointestinal endoscopy after non-Q wave myocardial infarction","volume":"28","author":"Montalvo RD","year":"1996","unstructured":"Montalvo RD, Lee M. Risks of upper gastrointestinal endoscopy after non-Q wave myocardial infarction. Endoscopy. 1996, 28:329. 10.1055\/s-2007-1005473","journal-title":"Endoscopy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.06.024","article-title":"Safety and efficacy of ERCP after recent myocardial infarction or unstable angina","volume":"72","author":"Nojkov B","year":"2010","unstructured":"Nojkov B, Cappell MS. Safety and efficacy of ERCP after recent myocardial infarction or unstable angina. Gastrointest Endosc. 2010, 72:870-80. 10.1016\/j.gie.2010.06.024","journal-title":"Gastrointest Endosc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28310","article-title":"Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement","volume":"94","author":"Mohananey D","year":"2019","unstructured":"Mohananey D, Villablanca P, Gupta T, et al.. Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019, 94:249-55. 10.1002\/ccd.28310","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song P","year":"2019","unstructured":"Song P, Rudan D, Zhu Y, et al.. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019, 7:1020-30. 10.1016\/S2214-109X(19)30255-4","journal-title":"Lancet Glob Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-14-0062","article-title":"Lifestyle and dietary risk factors for peripheral artery disease","volume":"78","author":"Ruiz-Canela M","year":"2014","unstructured":"Ruiz-Canela M, Mart\u00ednez-Gonz\u00e1lez MA. Lifestyle and dietary risk factors for peripheral artery disease. Circ J. 2014, 78:553-9. 10.1253\/circj.cj-14-0062","journal-title":"Circ J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.182452","article-title":"Outcome of acute upper gastrointestinal bleeding in patients with coronary artery disease: A matched case-control study","volume":"22","author":"Thanapirom K","year":"2016","unstructured":"Thanapirom K, Ridtitid W, Rerknimitr R, et al.. Outcome of acute upper gastrointestinal bleeding in patients with coronary artery disease: A matched case-control study. Saudi J Gastroenterol. 2016, 22:203-7. 10.4103\/1319-3767.182452","journal-title":"Saudi J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand SS","year":"2018","unstructured":"Anand SS, Bosch J, Eikelboom JW, et al.. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018, 391:219-29. 10.1016\/S0140-6736(17)32409-1","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046448","article-title":"Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial","volume":"141","author":"Bhatt DL","year":"2020","unstructured":"Bhatt DL, Eikelboom JW, Connolly SJ, et al.. Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial. Circulation. 2020, 141:1841-54. 10.1161\/CIRCULATIONAHA.120.046448","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca MP","year":"2020","unstructured":"Bonaca MP, Bauersachs RM, Anand SS, et al.. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020, 382:1994-2004. 10.1056\/NEJMoa2000052","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17204","article-title":"Post-ERCP bleeding in the era of multiple antiplatelet agents","volume":"12","author":"Oh HC","year":"2018","unstructured":"Oh HC, El Hajj II, Easler JJ, et al.. Post-ERCP bleeding in the era of multiple antiplatelet agents. Gut Liver. 2018, 12:214-8. 10.5009\/gnl17204","journal-title":"Gut Liver"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer BJ","year":"2012","unstructured":"Elmunzer BJ, Scheiman JM, Lehman GA, et al.. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012, 366:1414-22. 10.1056\/NEJMoa1111103","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2017.01.033","article-title":"Indomethacin and diclofenac in the prevention of post-ERCP\u00a0pancreatitis: a systematic review and meta-analysis\u00a0of prospective controlled trials","volume":"85","author":"Patai \u00c1","year":"2017","unstructured":"Patai \u00c1, Solymosi N, Moh\u00e1csi L, Patai \u00c1V. Indomethacin and diclofenac in the prevention of post-ERCP\u00a0pancreatitis: a systematic review and meta-analysis\u00a0of prospective controlled trials. Gastrointest Endosc. 2017, 85:1144-56. 10.1016\/j.gie.2017.01.033","journal-title":"Gastrointest Endosc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0837-4","article-title":"What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials","volume":"18","author":"Lyu Y","year":"2018","unstructured":"Lyu Y, Cheng Y, Wang B, Xu Y, Du W. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2018, 18:106. 10.1186\/s12876-018-0837-4","journal-title":"BMC Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13921","article-title":"Endoscopic retrograde cholangiopancreatography in patients with versus without prior myocardial infarction or coronary revascularization: a nationwide cohort study","volume":"13","author":"Patel HK","year":"2021","unstructured":"Patel HK, Desai R, Doshi S, et al.. Endoscopic retrograde cholangiopancreatography in patients with versus without prior myocardial infarction or coronary revascularization: a nationwide cohort study. Cureus. 2021, 13:e13921. 10.7759\/cureus.13921","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.12.014","article-title":"Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters","volume":"49","author":"Sedlacek M","year":"2007","unstructured":"Sedlacek M, Gemery JM, Cheung AL, Bayer AS, Remillard BD. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis. 2007, 49:401-8. 10.1053\/j.ajkd.2006.12.014","journal-title":"Am J Kidney Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2009.04205.x","article-title":"The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents","volume":"107","author":"Al-Bakri AG","year":"2009","unstructured":"Al-Bakri AG, Othman G, Bustanji Y. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J Appl Microbiol. 2009, 107:280-6. 10.1111\/j.1365-2672.2009.04205.x","journal-title":"J Appl Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102407-outcomes-of-hospitalized-patients-undergoing-endoscopic-retrograde-cholangiopancreatography-ercp-with-and-without-a-history-of-peripheral-artery-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:14Z","timestamp":1707507554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102407-outcomes-of-hospitalized-patients-undergoing-endoscopic-retrograde-cholangiopancreatography-ercp-with-and-without-a-history-of-peripheral-artery-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.26585","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}